TRAMP prostate tumor growth is slowed by walnut diets through altered IGF-1 levels, energy pathways, and cholesterol metabolism

Journal of Medicinal Food

Volumn 17, Issue 12, 2014, Pages 1281-1286

  Kim, Hyunsook ^a   Yokoyama, Wallace ^b   Davis, Paul Andrew ^c  

^a Konkuk University   (South Korea)

^b WESTERN REGIONAL RESEARCH CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

chemoprevention; fat; insulin like growth factor 1; prostate cancer; transgenic adenocarcinoma of the mouse prostate model; walnut; whole foods

Indexed keywords

4 HYDROXYBUTYRIC ACID; ALPHA TOCOPHEROL; CHOLESTEROL; GAMMA TOCOPHEROL; GLUCOSE 6 PHOSPHATE; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; MESSENGER RNA; SOMATOMEDIN C; SUCCINYLCARNITINE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; FAT INTAKE; TOCOPHEROL; VEGETABLE OIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DIET; ENERGY; ENERGY METABOLISM; FOOD COMPOSITION; GLUCONEOGENESIS; GLUCOSE METABOLISM; INSULIN SENSITIVITY; MACRONUTRIENT; MALE; METABOLOMICS; MOUSE; NONHUMAN; PROSTATE TUMOR; PROTEIN EXPRESSION; TRANSGENIC ADENOCARCINOMA OF THE MOUSE PROSTATE PROSTATE TUMOR; TRIACYLGLYCEROL BLOOD LEVEL; WALNUT; ADENOCARCINOMA; ANALYSIS; ANIMAL; BLOOD; C57BL MOUSE; CHEMISTRY; DIET THERAPY; FAT INTAKE; METABOLISM; PROSTATE; TRANSGENIC MOUSE;

JUGLANS;

ADENOCARCINOMA; ANIMALS; CHOLESTEROL; DIETARY FATS; ENERGY METABOLISM; INSULIN-LIKE GROWTH FACTOR I; JUGLANS; LIPOPROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PLANT OILS; PROSTATE; PROSTATIC NEOPLASMS; RNA, MESSENGER; TOCOPHEROLS;

EID: 84915759884     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2014.0061     Document Type: Article

References (42)

1. Ibarrola-Jurado N, Bullo M, Guasch-Ferre M, et al. Crosssectional assessment of nut consumption and obesity, metabolic syndrome and other cardiometabolic risk factors. The PREDIMED study. PLoS One 2013;8:e57367
2. Haddad EH, Gaban-Chong N, Oda K, Sabate J. Effect of a walnut meal on postprandial oxidative stress and antioxidants in healthy individuals. Nutr J 2014;13:4
3. Guasch-Ferre M, Bullo M, Martinez-Gonzalez MA, et al. Frequency of nut consumption and mortality risk in the PREDIMED nutrition intervention trial. BMC Med 2013;11:164
4. Bao Y, Han J, Hu FB, et al. Association of nut consumption with total and cause-specific mortality. N Engl J Med 2013;369:2001-2011
5. Davis P, Valacchi G, Pagnin E, et al. Walnuts reduce aortic ET-1 mRNA levels in hamsters fed a high-fat, atherogenic diet. J Nutr 2006;136:428-432
6. Hardman WE, Ion G. Suppression of implanted MDA-MB 231 human breast cancer growth in nude mice by dietary walnut. Nutr Cancer 2008;60:666-674
7. Hardman WE, Ion G, Akinsete JA, Witte TR. Dietary walnut suppressed mammary gland tumorigenesis in the C(3)1 TAg mouse. Nutr Cancer 2011;63:960-970
8. Davis PA, Vasu VT, Gohil K, et al. A high-fat diet containing whole walnuts ( Juglans regia) reduces tumour size and growth along with plasma insulin-like growth factor 1 in the transgenic adenocarcinoma of the mouse prostate model. Br J Nutr 2012; 108:1764-1772
9. Nagel JM, Brinkoetter M, Magkos F, et al. Dietary walnuts inhibit colorectal cancer growth in mice by suppressing angiogenesis. Nutrition 2012;28:67-75
10. Reiter RJ, Tan DX, Manchester LC, et al. A walnut-enriched diet reduces the growth of LNCaP human prostate cancer xenografts in nude mice. Cancer Invest 2013;31:365-373
11. Russo GL. Dietary n-6 and n-3 polyunsaturated fatty acids. from biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol 2009;77:937-946
12. Hanahan D, Weinberg RA. Hallmarks of cancer. The next generation. Cell 2011;144:646-674
13. Li H, Handsaker B, Wysoker A, et al. The sequence alignment/Map format and SAMtools. Bioinformatics 2009;25:2078-2079
14. Adhami VM, Siddiqui IA, Ahmad N, Gupta S, Mukhtar H. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res 2004;64:8715-8722
15. Lee IH, Hong X, Mathur SC, et al. A detailed analysis of next generation sequencing reads of microRNA expression in Barrett's esophagus. absolute versus relative quantification. BMC Res Notes 2014;7:212
16. Kolonel LN, Nomura AM, Cooney RV. Dietary fat and prostate cancer. current status. J Natl Cancer Inst 1999;91:414-428
17. Villeneuve PJ, Johnson KC, Kreiger N, Mao Y. Risk factors for prostate cancer. results from the Canadian National Enhanced Cancer Surveillance System. The Canadian Cancer Registries Epidemiology Research Group. Cancer Causes Control 1999;10: 355-367
18. Kolonel LN. Fat, meat, and prostate cancer. Epidemiol Rev 2001;23:72-81
19. Chan JM, Gann PH, Giovannucci EL. Role of diet in prostate cancer development and progression. J Clin Oncol 2005;23: 8152-8160
20. Lloyd JC, Antonelli JA, Phillips TE, et al. Effect of isocaloric low fat diet on prostate cancer xenograft progression in a hormone deprivation model. J Urol 2010;183:1619-1624
21. Lloyd JC, Masko EM, Wu C, et al. Fish oil slows prostate cancer xenograft growth relative to other dietary fats and is associated with decreased mitochondrial and insulin pathway gene expression prostate Cancer Prostatic Dis 2013;16:285-291
22. Sanches LD, Santos SA, Carvalho JR, et al protective effect of gamma-tocopherol-enriched diet on N-methyl-N-nitrosoureainduced epithelial dysplasia in rat ventral prostate. Int J Exp Pathol 2013;94:362-372
23. Zhuang L, Kim J, Adam RM, Solomon KR, Freeman MR. Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. J Clin Invest 2005; 115:959-968
24. Llaverias G, Danilo C, Wang Y, et al. A Western-type diet accelerates tumor progression in an autochthonous mouse model of prostate cancer. Am J Pathol 2010;177:3180-3191
25. Hurwitz AA, Foster BA, Allison JP, Greenberg NM, Kwon ED. The TRAMP mouse as a model for prostate cancer. Curr Protoc Immunol 2001;Chapter 20:Unit 20.5
26. Key TJ. Diet, insulin-like growth factor-1 and cancer risk proc Nutr Soc 2011;3:1-4
27. Nogueira LM, Lavigne JA, Chandramouli GV, Lui H, Barrett JC, Hursting SD. Dose-dependent effects of calorie restriction on gene expression, metabolism, and tumor progression are partially mediated by insulin-like growth factor-1. Cancer Med 2012; 1:275-288
28. Puri V, Ranjit S, Konda S, et al. Cidea is associated with lipid droplets and insulin sensitivity in humans proc Natl Acad Sci USA 2008;105:7833-7838
29. Tilghman SM, Hanson RW, Reshef L, Hopgood MF, Ballard FJ. Rapid loss of translatable messenger RNA of phosphoenolpyruvate carboxykinase during glucose repression in liver proc Natl Acad Sci USA 1974;71:1304-1308
30. Chiba T, Komatsu T, Nakayama M, et al. Similar metabolic responses to calorie restriction in lean and obese Zucker rats. Mol Cell Endocrinol 2009;309:17-25
31. Michalakis K, Williams CJ, Mitsiades N, et al. Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study. Cancer Epidemiol Biomarkers Prev 2007;16:308-313
32. Sher DJ, Oh WK, Jacobus S, Regan NM, Lee GS, Mantzoros C. Relationship between serum adiponectin and prostate cancer grade prostate 2008;68:1592-1598
33. Arisan ED, Arisan S, Atis G, Palavan-Unsal N, Ergenekon E. Serum adipocytokine levels in prostate cancer patients. Urol Int 2009;82:203-208
34. Shukeir N, Arakelian A, Kadhim S, Garde S, Rabbani SA prostate secretory protein PSP-94 decreases tumor growth and hypercalcemia of malignancy in a syngenic in vivo model of prostate cancer. Cancer Res 2003;63:2072-2078
35. Reeves JR, Dulude H, Panchal, C, Daigneault L, Ramnani DM prognostic value of prostate secretory protein of 94 amino acids and its binding protein after radical prostatectomy. Clin Cancer Res 2006;12(20 Pt 1):6018-6022
36. Shanmugam MK, Ong TH, Kumar AP, et al. Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways. PLoS One 2012;7:e32476
37. Strand DW, Jiang M, Murphy TA, et al. PPARy isoforms differentially regulate metabolic networks to mediate mouse prostatic epithelial differentiation. Cell Death Dis 2012;3:e361
38. Cabre A, Lazaro I, Girona J, et al. Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients. Atherosclerosis 2007;195:e150-e158
39. Vanden Heuvel JP, Belda BJ, Hannon DB, et al. Mechanistic examination of walnuts in prevention of breast cancer. Nutr Cancer 2012;64:1078-1086
40. Hafeez BB, Zhong W, Mustafa A, Fischer JW, Witkowsky O, Verma AK. Plumbagin inhibits prostate cancer development in TRAMP mice via targeting PKCepsilon, Stat3 and neuroendocrine markers. Carcinogenesis 2012;33:2586-2592
41. Luu W, Sharpe LJ, Stevenson J, Brown AJ. Akt acutely activates the cholesterogenic transcription factor SREBP-2. Biochim Biophys Acta 2012;1823:458-464
42. Luo Y, Yang C, Ye M, et al. Deficiency of metabolic regulator FGFR4 delays breast cancer progression through systemic and microenvironmental metabolic alterations. Cancer Metab 2013;1:21